• Baicalin Methyl Ester Alleviates LPS-Induced Intestinal Dama

  2026-06-02

  Liang et al. (2024) demonstrate that baicalin methyl ester (BME), an esterified derivative of baicalin, robustly protects against LPS-induced intestinal barrier damage in mice and MODE-K cells, primarily by modulating the P65/TNF-α/MLCK/ZO-1 pathway. The findings provide mechanistic clarity and preclinical protocol guidance for researchers studying intestinal inflammation and barrier dysfunction.

• Aprotinin (Bovine Pancreatic Trypsin Inhibitor): Applied Wor

  2026-06-02

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) empowers researchers to precisely inhibit serine proteases, reduce perioperative blood loss, and enhance assay reliability. This guide details experimental workflows, protocol optimization, and troubleshooting tips, leveraging both cutting-edge research and APExBIO’s robust product formulation.

• Technical Use of PKH26 Red Fluorescent Cell Linker Kit (K241

  2026-06-01

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, membrane-specific labeling for cell tracing and proliferation analysis in vitro and in vivo. It should only be applied to the cell membrane lipid region and is not intended for intracellular or non-membrane applications. Proper storage and adherence to protocol are necessary to ensure reproducible, low-toxicity results.

• NF 449 as a Highly Potent and Selective P2X1 Receptor Antago

  2026-06-01

  The reference study rigorously characterizes NF 449 as the most potent and subtype-selective antagonist of P2X1-containing ion channels to date, enabling precise dissection of purinergic signaling. This specificity has key implications for platelet aggregation research and the development of targeted antithrombotic agents.

• Tamoxifen: Mechanisms, Benchmarks, and Research Protocols

  2026-05-31

  Tamoxifen, a selective estrogen receptor modulator, is foundational in breast cancer research and gene knockout studies. Its multifaceted mechanisms and rigorous benchmarks underpin its wide adoption in translational science.

• T-5224: Precision Inhibition of AP-1 in Neuroinflammation Re

  2026-05-30

  Explore how T-5224, a selective C-Fos/AP-1 inhibitor, enables advanced modulation of neuroinflammatory and arthritic pathways. This article uncovers mechanistic insights and assay protocols, offering unique practical guidance for inflammation research.

• Triacetin Digestion and Hepatic Metabolic Modulation in Rats

  2026-05-29

  This study clarifies the digestive fate of triacetin, a short-chain triacylglycerol, in rats. By tracking its rapid conversion to acetic acid and glycerol in the upper gut and subsequent effects on hepatic metabolism, the research reveals triacetin's dual role as both an energy substrate and a modulator of liver gene expression.

• Translating EZ Cap™ Cre mRNA (m1Ψ): Next-Gen Gene Editing

  2026-05-29

  This thought-leadership article explores mechanistic and translational advances in Cre recombinase mRNA technology. It blends insights on mRNA stability, delivery innovations, and actionable protocol guidance, highlighting the unique capabilities of APExBIO’s EZ Cap™ Cre mRNA (m1Ψ) for gene editing beyond hepatic tissues. Drawing from recent breakthroughs in virus-mimicking delivery systems, it offers translational researchers an integrated strategy for deploying high-performance mRNA reagents in advanced functional genomics and gene therapy research.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Research

  2026-05-28

  Salinomycin is a polyether ionophore antibiotic with robust, experimentally validated anti-cancer properties, notably against hepatocellular carcinoma (HCC). Its dual mechanism—Wnt/β-catenin pathway inhibition and ABC transporter interference—makes it a potent apoptosis inducer in cancer research models.

• PF-562271 HCl: Precision FAK/Pyk2 Inhibitor in Cancer Resear

  2026-05-28

  PF-562271 HCl stands out as a nanomolar-potency, reversible FAK/Pyk2 inhibitor, enabling researchers to dissect tumor signaling, growth, and microenvironment modulation with exceptional specificity. Its robust selectivity profile and reproducible inhibition of FAK phosphorylation make it a cornerstone for advanced cancer research workflows, especially in studies seeking to optimize immunotherapy strategies.

• PF-562271 HCl: Unveiling FAK/Pyk2 Inhibition in Pre-Metastat

  2026-05-27

  Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, advances cancer research by targeting the early cellular events of pre-metastatic niche formation. This in-depth analysis uniquely bridges kinase inhibition with insights from polyploid giant cancer cell biology.

• α-KG Restores HPDLSC Function in Periodontitis via LKB1-AMPK

  2026-05-27

  This study demonstrates that α-ketoglutarate (α-KG) alleviates mitochondrial dysfunction and cellular senescence in human periodontal ligament stem cells (HPDLSCs) under inflammatory conditions by activating the LKB1-AMPK signaling pathway. These findings reveal a potential therapeutic route for promoting periodontal regeneration in chronic periodontitis.

• Cefepime (BMY-28142): Translational Leverage in CNS Infectio

  2026-05-26

  This article explores the mechanistic and translational nuances of Cefepime (BMY-28142) in central nervous system infection research, offering strategic protocol guidance and context for antimicrobial resistance modeling. By synthesizing recent evidence, competitive insights, and practical workflow recommendations, it equips translational researchers with actionable intelligence for optimizing experimental design and data quality.

• Reliable PI3K/Akt Pathway Inhibition in Cancer with GDC-0941

  2026-05-26

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, providing scenario-driven guidance for using GDC-0941 (SKU A8210) as a selective PI3K inhibitor. It highlights best practices, protocol optimization, and vendor selection strategies grounded in quantitative data, ensuring reproducible and robust results.

• Micro- and Nanoplastics Heighten Pulmonary Fibrosis via FXR-

  2026-05-25

  This study provides a comparative evaluation of microplastics (MPs) and nanoplastics (NPs) from different polymers, revealing that both size and type critically influence pulmonary toxicity and fibrosis risk. Mechanistic insights implicate dysregulation of the FXR-YAP1 axis as a central driver, with polystyrene nanoplastics exhibiting the highest fibrogenic potential.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page